SAN DIEGO (AP) — Harrow Health, Inc. (HROW) on Wednesday reported a second-quarter loss of $2.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the San Diego-based company said it had a loss of 9 cents.

The pharmaceutical and drug compounding company posted revenue of $13.5 million in the period.

Harrow shares have climbed 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.40, more than doubling in the last 12 months.

—————

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HROW at https://www.zacks.com/ap/HROW

Automated Insights

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Thank you for reading the Daily Journal.

Please purchase an Enhanced Subscription to continue reading.Please log in, or sign up for a new account and purchase an Enhanced Subscription to continue reading.